These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3447446)

  • 1. Removal of small proteins--the stepchild of dialysis therapy. Protein permeability of different hemofiltration membranes analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
    Birk HW; Wizeman V
    Adv Exp Med Biol; 1987; 223():277-80. PubMed ID: 3447446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemofiltration and the middle molecule.
    Henderson LW
    Blood Purif; 1999; 17(4):175-7. PubMed ID: 10494018
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteomic analisys of protein extraction during hemofiltration with on-line endogenous reinfusion (HFR) using different polysulphone membranes.
    Monari E; Cuoghi A; Bellei E; Bergamini S; Caiazzo M; Aucella F; Loschiavo C; Corazza L; Palladino G; Sereni L; Atti M; Tomasi A
    J Mater Sci Mater Med; 2014 Dec; 25(12):2691-8. PubMed ID: 25074835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of high-performance membranes - from the clinical point of view.
    Saito A
    Contrib Nephrol; 2011; 173():1-10. PubMed ID: 21865770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pump assisted continuous venovenous hemofiltration for treating acute uremia.
    Canaud B; Garred LJ; Christol JP; Aubas S; Béraud JJ; Mion C
    Kidney Int Suppl; 1988 Mar; 24():S154-6. PubMed ID: 3163038
    [No Abstract]   [Full Text] [Related]  

  • 7. SDS-polyacrylamide electrophoresis of protein loss during continuous ambulatory peritoneal dialysis.
    Giangrande A; Limido A; Cantù P; Allaria P
    Ric Clin Lab; 1980; 10(1):117-20. PubMed ID: 7466153
    [No Abstract]   [Full Text] [Related]  

  • 8. Inadequate clearance of small molecular weight solutes during hemofiltration using Cuprophan membranes.
    Rubin JE; Adler AJ; Friedman EA; Berlyne GM
    Artif Organs; 1978 May; 2(2):125-7. PubMed ID: 687164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an erythropoietic inhibitor from the dialysate collected in the hemodialysis with PMMA membrane (BK-F).
    Yamada S; Kataoka H; Kobayashi H; Ono T; Minakuchi J; Kawano Y
    Contrib Nephrol; 1999; 125():159-72. PubMed ID: 9895438
    [No Abstract]   [Full Text] [Related]  

  • 10. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
    Montali U; Pilone N; Cioni L; Ronca G
    Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erosive osteoarthropathy associated with beta 2-microglobulin amyloidosis in a uraemic patient treated exclusively by long-term haemofiltration with biocompatible membranes.
    Renaud H; Fournier A; Moriniere P; Westeel PF; el Esper N; Belbrik S; Marie A; Cohen-Solal HE; Sebert JL
    Nephrol Dial Transplant; 1988; 3(6):820-2. PubMed ID: 3147427
    [No Abstract]   [Full Text] [Related]  

  • 12. Replacement of excretory kidney function by high-efficiency hemodiafiltration (HDF) with a peptide-permeable membrane.
    Wizemann V; Techert F; Brüning S; Birk HW; Mueller K
    Adv Exp Med Biol; 1987; 223():263-6. PubMed ID: 3447444
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical aspects of hemofiltration.
    von Herrath D; Schaefer K; Hufler M; Asmus G; Hensel A
    J Dial; 1977; 1(6):545-58. PubMed ID: 608866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced protein loss during hemofiltration using Cuprophan membranes.
    Rubin JE; Adler AJ; Friedman EA; Berlyne GM
    Artif Organs; 1978 May; 2(2):131-3. PubMed ID: 687166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing protein permeability of dialysis membranes using SDS-PAGE.
    Mann H; Melzer H; Al-Bashir A; Xu XQ; Stiller S
    Int J Artif Organs; 2002 May; 25(5):441-6. PubMed ID: 12074343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A compound inhibiting platelet aggregation in hemofiltrate from uremic patients.
    Tatsumi Y; Tatsumi J; Kojima K; Tatsumi N; Okuda K; Iritani Y; Ikeuchi H; Yamagami S
    Osaka City Med J; 1984 Jun; 30(1):31-8. PubMed ID: 6514335
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemofiltration redux.
    Ledebo I
    Blood Purif; 1999; 17(4):178-81. PubMed ID: 10494019
    [No Abstract]   [Full Text] [Related]  

  • 18. Membranes for blood purification: state of the art and new developments.
    Strathmann H; Göhl H
    Contrib Nephrol; 1990; 78():119-40; discussion 140-1. PubMed ID: 2225829
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemofiltration in uremia: clinical approach].
    Vantelon J; Lauriat F; Perrone B; Jeannot F
    J Urol Nephrol (Paris); 1977 Sep; 83(9):712-7. PubMed ID: 926235
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug removal during continuous hemofiltration or hemodialysis.
    Golper TA
    Contrib Nephrol; 1991; 93():110-6. PubMed ID: 1802557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.